Clinical Trials Logo

Clinical Trial Summary

Prospective study conducted on 150 women with polycystic ovarian syndrome (PCOS) were randomly divided into 3 groups: group I (50 women) received clomiphene citrate (CC) only 50 mg orally every 8 hours started from cycle day 3 for 5 days, group II (50 women) received 2mg estradiol valerate daily from cycle day 7 - 11 in addition to CC and group III (50 women) received phytoestrogen (20mg of cimifuga racemosa from day 1- 12) in addition to CC.


Clinical Trial Description

Prospective study conducted on 150 women with PCOS were randomly divided into 3 groups: group I (50 women) received CC only50 mg orally every 8 hours started from cycle day 3 for 5 days, group II (50 women) received 2mg estradiol valerate daily from cycle day 7 - 11 in addition to CC and group III (50 women) received phytoestrogen (20mg of cimifuga racemosa from day 1- 12) in addition to CC. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02352597
Study type Interventional
Source Cairo University
Contact
Status Completed
Phase Phase 4
Start date January 2013
Completion date January 2015

See also
  Status Clinical Trial Phase
Not yet recruiting NCT00631982 - Invitro Maturation of Oocytes for Patients With Polycystic Ovaries N/A